A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein
Joseph O. Carver(National Cancer Institute), Ji Luo(Center for Cancer Research)
Cited by 20
Related Papers
Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9
|Proceedings of the National Academy of Sciences|2015|75
A Nonconserved Histidine Residue on KRAS Drives Paralog Selectivity of the KRASG12D Inhibitor MRTX1133
|Cancer Research|2023|19
One-step immortalization of primary human airway epithelial cells capable of oncogenic transformation
|Cell & Bioscience|2016|13
A non-conserved histidine residue on KRAS drives paralog selectivity of the KRAS G12D inhibitor MRTX1133
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1